REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
02/18/2025
Back to search
Official data from USPTO
POLYNAUT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
02/18/2025
Trademark type
Word
Nice classes
1, 5
Filing date
01/14/2019
Registration date
02/18/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/18/2020
Last transaction
02/18/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
24
Owner location
HISTON, CAMBRIDGE, GB
Examiner
WILSON, MARYNELLE
Law office
M40
Current location
TMO LAW OFFICE 113
Holders and representatives
Holders
SOMASERVE LIMITED
Somanautix Limited
Representatives
Ben Natter HAUG PARTNERS LLP
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals used in science; chemicals for encapsulatingmicroencapsulating and decapsulating other chemicals; chemicals for the protectiondeliverytransport and triggered or controlled release of other chemicals; chemicals for encapsulatingmicroencapsulating and decapsulating biologically active ingredients including enzymes and cells; reagents and diagnostic preparations for scientific or medical research useclinical or medical laboratory use in oncology; targeted diagnostic preparations for scientific or medical research useclinical or medical laboratory use in oncology
Class 5
Pharmaceutical preparations for the treatment and prevention of infectiousautoimmuneviralmetabolicmusculoskeletalcardiovasculargenitourinarycentral nervous systemendocrinologicalimmunologicalobstetricalgynaecologicaloncologicalrespiratoryneurologicalgastrointestinalhormonaldermatological and psychiatric diseases and disorders; reagentsdiagnostics and therapeutic preparations for medical and veterinary use in oncology; therapeutic preparations for use in treating cancer in medical and veterinary patients; targeted medical and veterinary preparations for use in oncology; medical and veterinary preparations for use in chemotherapy and immunotherapy for the treatment and prevention of infectiousautoimmuneviralmetabolicmusculoskeletalcardiovasculargenitourinarycentral nervous systemendocrinologicalimmunologicalobstetricalgynaecologicaloncologicalrespiratoryneurologicalgastrointestinalhormonaldermatological and psychiatric diseases and disorders; medical and veterinary preparations for the delivery of compounds to the brain for the treatment and prevention of infectiousautoimmuneviralmetabolicmusculoskeletalcardiovasculargenitourinarycentral nervous systemendocrinologicalimmunologicalobstetricalgynaecologicaloncologicalrespiratoryneurologicalgastrointestinalhormonaldermatological and psychiatric diseases and disorders; medical and veterinary preparations for crossing the blood-brain barrier for the treatment and prevention of infectiousautoimmuneviralmetabolicmusculoskeletalcardiovasculargenitourinarycentral nervous systemendocrinologicalimmunologicalobstetricalgynaecologicaloncologicalrespiratoryneurologicalgastrointestinalhormonaldermatological and psychiatric diseases and disorders; medical and veterinary preparations for delivering reagentsdiagnostics and therapeutics across the blood-brain barrier for the treatment and prevention of infectiousautoimmuneviralmetabolicmusculoskeletalcardiovasculargenitourinarycentral nervous systemendocrinologicalimmunologicalobstetricalgynaecologicaloncologicalrespiratoryneurologicalgastrointestinalhormonaldermatological and psychiatric diseases and disorders
Publications
History of USPTO decisions and trademark events.
30 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/20/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/20/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/20/2022
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
12/30/2020
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
05/06/2020
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
05/05/2020
PRAM
POST REGISTRATION ACTION MAILED - SEC. 7
05/04/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/27/2020
ES7R
TEAS SECTION 7 REQUEST RECEIVED
03/21/2020
ES7R
TEAS SECTION 7 REQUEST RECEIVED
03/20/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
02/18/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/03/2019
PUBO
PUBLISHED FOR OPPOSITION
12/03/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/13/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/28/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
10/28/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/28/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
10/28/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/28/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/08/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/08/2019
ALIE
ASSIGNED TO LIE
10/07/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/01/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/03/2019
GNRT
NON-FINAL ACTION E-MAILED
04/03/2019
CNRT
NON-FINAL ACTION WRITTEN
04/03/2019
DOCK
ASSIGNED TO EXAMINER
03/27/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/07/2019
NWAP
NEW APPLICATION ENTERED
01/17/2019
Continuous trademark protection
Get notified about every new filing that threatens POLYNAUT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.